Search Tag: Novo Nordisk

2024 21 Jun

  The World Health Organization (WHO) has issued a global alert about fake versions of Ozempic, a drug that has gained significant popularity for weight loss. Although Ozempic is primarily prescribed for type 2 diabetes, it is sometimes referred to as a "skinny jab" due to its weight-loss effects. The WHO has warned that the fake versions of Ozempic...Read more

2023 05 Sep

Novo Nordisk, the Danish pharmaceutical giant behind the weight-loss medication Wegovy (active ingredient - semaglutide), has become Europe's most valuable company, dethroning the French luxury conglomerate LVMH.   Following the successful launch of Wegovy in the U.K., the company's shares saw a significant uptick in value. As trading closed...Read more